IBDEI31H ; ; 04-FEB-2020
;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
Q:'DIFQR(358.3) F I=1:2 S X=$T(Q+I) Q:X="" S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E S @X=Y
Q Q
;;^UTILITY(U,$J,358.3,48529,1,3,0)
;;=3^Muscle Wasting/Atrophy,Unspec Site NEC
;;^UTILITY(U,$J,358.3,48529,1,4,0)
;;=4^M62.50
;;^UTILITY(U,$J,358.3,48529,2)
;;=^5012655
;;^UTILITY(U,$J,358.3,48530,0)
;;=M62.81^^185^2423^89
;;^UTILITY(U,$J,358.3,48530,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,48530,1,3,0)
;;=3^Muscle Weakness,Generalized
;;^UTILITY(U,$J,358.3,48530,1,4,0)
;;=4^M62.81
;;^UTILITY(U,$J,358.3,48530,2)
;;=^332922
;;^UTILITY(U,$J,358.3,48531,0)
;;=M61.9^^185^2423^90
;;^UTILITY(U,$J,358.3,48531,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,48531,1,3,0)
;;=3^Muscle,Calcification/Ossification,Unspec
;;^UTILITY(U,$J,358.3,48531,1,4,0)
;;=4^M61.9
;;^UTILITY(U,$J,358.3,48531,2)
;;=^5012561
;;^UTILITY(U,$J,358.3,48532,0)
;;=M62.40^^185^2423^91
;;^UTILITY(U,$J,358.3,48532,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,48532,1,3,0)
;;=3^Muscle,Contracture,Unspec Site
;;^UTILITY(U,$J,358.3,48532,1,4,0)
;;=4^M62.40
;;^UTILITY(U,$J,358.3,48532,2)
;;=^5012631
;;^UTILITY(U,$J,358.3,48533,0)
;;=M62.9^^185^2423^84
;;^UTILITY(U,$J,358.3,48533,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,48533,1,3,0)
;;=3^Muscle Disorder,Unspec
;;^UTILITY(U,$J,358.3,48533,1,4,0)
;;=4^M62.9
;;^UTILITY(U,$J,358.3,48533,2)
;;=^5012684
;;^UTILITY(U,$J,358.3,48534,0)
;;=M62.20^^185^2423^92
;;^UTILITY(U,$J,358.3,48534,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,48534,1,3,0)
;;=3^Muscle,Nontraumatic Ischemic Infarction,Unspec Site
;;^UTILITY(U,$J,358.3,48534,1,4,0)
;;=4^M62.20
;;^UTILITY(U,$J,358.3,48534,2)
;;=^5012607
;;^UTILITY(U,$J,358.3,48535,0)
;;=G72.1^^185^2423^94
;;^UTILITY(U,$J,358.3,48535,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,48535,1,3,0)
;;=3^Myopathy,Alcoholic
;;^UTILITY(U,$J,358.3,48535,1,4,0)
;;=4^G72.1
;;^UTILITY(U,$J,358.3,48535,2)
;;=^5004096
;;^UTILITY(U,$J,358.3,48536,0)
;;=G72.81^^185^2423^95
;;^UTILITY(U,$J,358.3,48536,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,48536,1,3,0)
;;=3^Myopathy,Critical Illness
;;^UTILITY(U,$J,358.3,48536,1,4,0)
;;=4^G72.81
;;^UTILITY(U,$J,358.3,48536,2)
;;=^328484
;;^UTILITY(U,$J,358.3,48537,0)
;;=G72.0^^185^2423^96
;;^UTILITY(U,$J,358.3,48537,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,48537,1,3,0)
;;=3^Myopathy,Drug-Induced
;;^UTILITY(U,$J,358.3,48537,1,4,0)
;;=4^G72.0
;;^UTILITY(U,$J,358.3,48537,2)
;;=^5004095
;;^UTILITY(U,$J,358.3,48538,0)
;;=G72.41^^185^2423^97
;;^UTILITY(U,$J,358.3,48538,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,48538,1,3,0)
;;=3^Myopathy,Inclusion Body Myositis
;;^UTILITY(U,$J,358.3,48538,1,4,0)
;;=4^G72.41
;;^UTILITY(U,$J,358.3,48538,2)
;;=^5004098
;;^UTILITY(U,$J,358.3,48539,0)
;;=G72.49^^185^2423^98
;;^UTILITY(U,$J,358.3,48539,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,48539,1,3,0)
;;=3^Myopathy,Inflammatory/Immune NEC
;;^UTILITY(U,$J,358.3,48539,1,4,0)
;;=4^G72.49
;;^UTILITY(U,$J,358.3,48539,2)
;;=^5004099
;;^UTILITY(U,$J,358.3,48540,0)
;;=G72.2^^185^2423^99
;;^UTILITY(U,$J,358.3,48540,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,48540,1,3,0)
;;=3^Myopathy,Other Toxic Agents
;;^UTILITY(U,$J,358.3,48540,1,4,0)
;;=4^G72.2
;;^UTILITY(U,$J,358.3,48540,2)
;;=^5004097
;;^UTILITY(U,$J,358.3,48541,0)
;;=G72.3^^185^2423^100
;;^UTILITY(U,$J,358.3,48541,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,48541,1,3,0)
;;=3^Myopathy,Periodic Paralysis
;;^UTILITY(U,$J,358.3,48541,1,4,0)
;;=4^G72.3
--- Routine Detail --- with STRUCTURED ROUTINE LISTING ---[H[J[2J[HIBDEI31H 3789 printed Dec 13, 2024@02:39:57 Page 2
IBDEI31H ; ; 04-FEB-2020
+1 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
+2 if 'DIFQR(358.3)
QUIT
FOR I=1:2
SET X=$TEXT(Q+I)
if X=""
QUIT
SET Y=$EXTRACT($TEXT(Q+I+1),4,999)
SET X=$EXTRACT(X,4,999)
if $ASCII(Y)=126
SET I=I+1
SET Y=$EXTRACT(Y,2,999)_$EXTRACT($TEXT(Q+I+1),5,999)
if $ASCII(Y)=61
SET Y=$EXTRACT(Y,2,999)
XECUTE NO
IF '$TEST
SET @X=Y
Q QUIT
+1 ;;^UTILITY(U,$J,358.3,48529,1,3,0)
+2 ;;=3^Muscle Wasting/Atrophy,Unspec Site NEC
+3 ;;^UTILITY(U,$J,358.3,48529,1,4,0)
+4 ;;=4^M62.50
+5 ;;^UTILITY(U,$J,358.3,48529,2)
+6 ;;=^5012655
+7 ;;^UTILITY(U,$J,358.3,48530,0)
+8 ;;=M62.81^^185^2423^89
+9 ;;^UTILITY(U,$J,358.3,48530,1,0)
+10 ;;=^358.31IA^4^2
+11 ;;^UTILITY(U,$J,358.3,48530,1,3,0)
+12 ;;=3^Muscle Weakness,Generalized
+13 ;;^UTILITY(U,$J,358.3,48530,1,4,0)
+14 ;;=4^M62.81
+15 ;;^UTILITY(U,$J,358.3,48530,2)
+16 ;;=^332922
+17 ;;^UTILITY(U,$J,358.3,48531,0)
+18 ;;=M61.9^^185^2423^90
+19 ;;^UTILITY(U,$J,358.3,48531,1,0)
+20 ;;=^358.31IA^4^2
+21 ;;^UTILITY(U,$J,358.3,48531,1,3,0)
+22 ;;=3^Muscle,Calcification/Ossification,Unspec
+23 ;;^UTILITY(U,$J,358.3,48531,1,4,0)
+24 ;;=4^M61.9
+25 ;;^UTILITY(U,$J,358.3,48531,2)
+26 ;;=^5012561
+27 ;;^UTILITY(U,$J,358.3,48532,0)
+28 ;;=M62.40^^185^2423^91
+29 ;;^UTILITY(U,$J,358.3,48532,1,0)
+30 ;;=^358.31IA^4^2
+31 ;;^UTILITY(U,$J,358.3,48532,1,3,0)
+32 ;;=3^Muscle,Contracture,Unspec Site
+33 ;;^UTILITY(U,$J,358.3,48532,1,4,0)
+34 ;;=4^M62.40
+35 ;;^UTILITY(U,$J,358.3,48532,2)
+36 ;;=^5012631
+37 ;;^UTILITY(U,$J,358.3,48533,0)
+38 ;;=M62.9^^185^2423^84
+39 ;;^UTILITY(U,$J,358.3,48533,1,0)
+40 ;;=^358.31IA^4^2
+41 ;;^UTILITY(U,$J,358.3,48533,1,3,0)
+42 ;;=3^Muscle Disorder,Unspec
+43 ;;^UTILITY(U,$J,358.3,48533,1,4,0)
+44 ;;=4^M62.9
+45 ;;^UTILITY(U,$J,358.3,48533,2)
+46 ;;=^5012684
+47 ;;^UTILITY(U,$J,358.3,48534,0)
+48 ;;=M62.20^^185^2423^92
+49 ;;^UTILITY(U,$J,358.3,48534,1,0)
+50 ;;=^358.31IA^4^2
+51 ;;^UTILITY(U,$J,358.3,48534,1,3,0)
+52 ;;=3^Muscle,Nontraumatic Ischemic Infarction,Unspec Site
+53 ;;^UTILITY(U,$J,358.3,48534,1,4,0)
+54 ;;=4^M62.20
+55 ;;^UTILITY(U,$J,358.3,48534,2)
+56 ;;=^5012607
+57 ;;^UTILITY(U,$J,358.3,48535,0)
+58 ;;=G72.1^^185^2423^94
+59 ;;^UTILITY(U,$J,358.3,48535,1,0)
+60 ;;=^358.31IA^4^2
+61 ;;^UTILITY(U,$J,358.3,48535,1,3,0)
+62 ;;=3^Myopathy,Alcoholic
+63 ;;^UTILITY(U,$J,358.3,48535,1,4,0)
+64 ;;=4^G72.1
+65 ;;^UTILITY(U,$J,358.3,48535,2)
+66 ;;=^5004096
+67 ;;^UTILITY(U,$J,358.3,48536,0)
+68 ;;=G72.81^^185^2423^95
+69 ;;^UTILITY(U,$J,358.3,48536,1,0)
+70 ;;=^358.31IA^4^2
+71 ;;^UTILITY(U,$J,358.3,48536,1,3,0)
+72 ;;=3^Myopathy,Critical Illness
+73 ;;^UTILITY(U,$J,358.3,48536,1,4,0)
+74 ;;=4^G72.81
+75 ;;^UTILITY(U,$J,358.3,48536,2)
+76 ;;=^328484
+77 ;;^UTILITY(U,$J,358.3,48537,0)
+78 ;;=G72.0^^185^2423^96
+79 ;;^UTILITY(U,$J,358.3,48537,1,0)
+80 ;;=^358.31IA^4^2
+81 ;;^UTILITY(U,$J,358.3,48537,1,3,0)
+82 ;;=3^Myopathy,Drug-Induced
+83 ;;^UTILITY(U,$J,358.3,48537,1,4,0)
+84 ;;=4^G72.0
+85 ;;^UTILITY(U,$J,358.3,48537,2)
+86 ;;=^5004095
+87 ;;^UTILITY(U,$J,358.3,48538,0)
+88 ;;=G72.41^^185^2423^97
+89 ;;^UTILITY(U,$J,358.3,48538,1,0)
+90 ;;=^358.31IA^4^2
+91 ;;^UTILITY(U,$J,358.3,48538,1,3,0)
+92 ;;=3^Myopathy,Inclusion Body Myositis
+93 ;;^UTILITY(U,$J,358.3,48538,1,4,0)
+94 ;;=4^G72.41
+95 ;;^UTILITY(U,$J,358.3,48538,2)
+96 ;;=^5004098
+97 ;;^UTILITY(U,$J,358.3,48539,0)
+98 ;;=G72.49^^185^2423^98
+99 ;;^UTILITY(U,$J,358.3,48539,1,0)
+100 ;;=^358.31IA^4^2
+101 ;;^UTILITY(U,$J,358.3,48539,1,3,0)
+102 ;;=3^Myopathy,Inflammatory/Immune NEC
+103 ;;^UTILITY(U,$J,358.3,48539,1,4,0)
+104 ;;=4^G72.49
+105 ;;^UTILITY(U,$J,358.3,48539,2)
+106 ;;=^5004099
+107 ;;^UTILITY(U,$J,358.3,48540,0)
+108 ;;=G72.2^^185^2423^99
+109 ;;^UTILITY(U,$J,358.3,48540,1,0)
+110 ;;=^358.31IA^4^2
+111 ;;^UTILITY(U,$J,358.3,48540,1,3,0)
+112 ;;=3^Myopathy,Other Toxic Agents
+113 ;;^UTILITY(U,$J,358.3,48540,1,4,0)
+114 ;;=4^G72.2
+115 ;;^UTILITY(U,$J,358.3,48540,2)
+116 ;;=^5004097
+117 ;;^UTILITY(U,$J,358.3,48541,0)
+118 ;;=G72.3^^185^2423^100
+119 ;;^UTILITY(U,$J,358.3,48541,1,0)
+120 ;;=^358.31IA^4^2
+121 ;;^UTILITY(U,$J,358.3,48541,1,3,0)
+122 ;;=3^Myopathy,Periodic Paralysis
+123 ;;^UTILITY(U,$J,358.3,48541,1,4,0)
+124 ;;=4^G72.3
